M Pharmaceutical Inc. - Developing Biomedical Technologies for Monitoring and Treatment of Obesity, Diabetes and More

M Pharmaceutical Inc. (CSE: MQ) (OTCQB: MPHMF) is a clinical-stage company developing technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications, according to the Company’s website (www.M-Pharma.ca). SNNLive spoke with Matthew Lehman, CEO of M Pharmaceutical Inc. at the SeeThruEquity Fall MicroCap Investor Conference 2015 in New York City, NY.

In this video interview, Mr. Lehman and our host discuss the following topics:

- Overview of M Pharmaceutical Inc.

- The Company’s technologies in development

- Discusses gastroenterological indications

- Science behind M Pharmaceuticals’s technology

- Market size for patients diagnosed with diabetes or as obese

- Where the technology comes from

- How the Company’s products are different

For more information about M Pharmaceutical Inc., go to: www.M-Pharma.ca